CLIMB BIO, INC. Increase (Decrease) in Other Noncurrent Assets
CLIMB BIO, INC. (CLYM) reported Increase (Decrease) in Other Noncurrent Assets of -$304.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- CLIMB BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$304.00K, a 122.65% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $162.00K.
- CLIMB BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was $1.51M, a 657.00% increase from fiscal 2024.
- CLIMB BIO, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was $200.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$304.00K 10-Q · filed 2026-08-06 | -$304.00K derived: sum of 3 quarters · filed 2026-08-06 | -$142.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $162.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $162.00K derived: sum of 2 quarters · filed 2026-03-05 | $1.50M derived: sum of 3 quarters · filed 2026-08-06 | $1.51M 10-K · filed 2026-03-05 |
| 2025-09-30 | $162.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.50M derived: sum of 2 quarters · filed 2026-08-06 | $1.51M 10-Q · filed 2025-11-06 | $1.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.35M 10-Q · filed 2026-08-06 | $1.57M derived: sum of 3 quarters · filed 2026-08-06 | $1.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-07 | $225.00K derived: sum of 2 quarters · filed 2026-05-07 | $225.00K derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | $215.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $215.00K derived: sum of 2 quarters · filed 2026-03-05 | $200.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$15.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$15.00K 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |